Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Surg Endosc. 2022 Feb;36(2):1044-1052. doi: 10.1007/s00464-021-08370-9. Epub 2021 Feb 26.
The effectiveness of subcostal transversus abdominis plane block (TAPB) in laparoscopic gastric cancer surgery is unknown. We aimed to investigate its opioid-sparing and pain-relief effects in laparoscopic gastrectomy for gastric cancer.
One hundred and twelve patients undergoing elective laparoscopic gastrectomy were randomised to the TAPB or control group. The TAPB group received ultrasound-guided bilateral subcostal TAPB at the end of surgery, while the control group did not. We investigated fentanyl consumption administered via intravenous patient-controlled analgesia and as a rescue analgesic, the numeric rating scale (NRS) pain scores at rest and during coughing, and the opioid-related side effects at 6, 12, 24, and 48 h postoperatively. The primary outcome was cumulative fentanyl consumption at 24 h postoperatively.
The study included 53 patients in each group. The cumulative fentanyl consumption 24 h postoperatively was significantly lower in the TAPB group than in the control group (median difference -170 mcg, P = 0.03, 95% CI -360 to -15 mcg). Subcostal TAPB also significantly reduced the resting NRS score at 48 h postoperatively (median difference -1, 95% CI -1 to 0, P = 0.01) and coughing NRS score at all time points (all median difference -1, 95% CI -2 to 0, P < 0.01, P = 0.02, 0.01, and 0.01, respectively). However, it did not reduce the occurrence of opioid-related side effects, except the use of antiemetics during the first 6 h postoperatively (TAPB, 1.9% vs. Control, 15.1%, P = 0.03).
Ultrasound-guided bilateral subcostal TAPB provides efficient postoperative analgesia with an opioid-sparing effect after laparoscopic gastrectomy.
肋缘下横腹直肌平面阻滞(TAPB)在腹腔镜胃癌手术中的有效性尚不清楚。我们旨在研究其在腹腔镜胃癌根治术中的阿片类药物节省和镇痛效果。
将 112 例行择期腹腔镜胃癌手术的患者随机分为 TAPB 组或对照组。TAPB 组在手术结束时接受超声引导下双侧肋缘下 TAPB,而对照组则不接受。我们调查了静脉患者自控镇痛(PCA)给予的芬太尼用量和作为解救性镇痛的静息和咳嗽时数字评分量表(NRS)疼痛评分,以及术后 6、12、24 和 48 小时的阿片类药物相关副作用。主要结局是术后 24 小时内的芬太尼累积消耗量。
每组纳入 53 例患者。术后 24 小时内 TAPB 组的芬太尼累积消耗量明显低于对照组(中位数差异-170 mcg,P=0.03,95%CI-360 至-15 mcg)。肋缘下 TAPB 还显著降低了术后 48 小时的静息 NRS 评分(中位数差异-1,95%CI-1 至 0,P=0.01)和咳嗽时的 NRS 评分(所有时间点中位数差异-1,95%CI-2 至 0,P<0.01,P=0.02,0.01 和 0.01)。然而,它并没有减少阿片类药物相关副作用的发生,除了术后前 6 小时使用止吐药(TAPB,1.9% vs. 对照组,15.1%,P=0.03)。
超声引导下双侧肋缘下 TAPB 可在腹腔镜胃癌手术后提供有效的术后镇痛,并具有阿片类药物节省作用。